Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Strowitzki, Thomas (VerfasserIn)
Dokumenttyp: Article (Journal) Buch/Monographie
Sprache:Englisch
Veröffentlicht: London BioMed Central 2016
Online-Zugang:Resolving-System, kostenfrei, Volltext: http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-200753
Volltext
Verfasserangaben:Thomas Strowitzki, Waldemar Kuczynski, Arnd Müller and Peter Bias

MARC

LEADER 00000cam a2200000 c 4500
001 1656587319
003 DE-627
005 20230426090043.0
007 cr uuu---uuuuu
008 160512s2016 xx |||||o 00| ||eng c
024 7 |a urn:nbn:de:bsz:16-heidok-200753  |2 urn 
024 7 |a 10.1186/s12958-015-0135-8  |2 doi 
035 |a (DE-627)1656587319 
035 |a (DE-576)46954712X 
035 |a (DE-599)BSZ46954712X 
035 |a (OCoLC)951113597 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
082 0 4 |a 610 
084 |a 33  |2 sdnb 
100 1 |a Strowitzki, Thomas  |d 1959-  |e VerfasserIn  |0 (DE-588)118055917  |0 (DE-627)079216099  |0 (DE-576)17102141X  |4 aut 
245 1 0 |a Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)  |c Thomas Strowitzki, Waldemar Kuczynski, Arnd Müller and Peter Bias 
264 1 |a London  |b BioMed Central  |c 2016 
300 |a 1 Online-Ressource (12 Seiten) 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Wissenschaftlicher Aufsatz. - Aus: Reproductive Biology and Endocrinology, 14 (2016), Nr. 1. pp. 1-12. ISSN 1477-7827 
856 4 0 |u http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-200753  |q application/pdf  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a BO 
992 |a 20160512 
993 |a Article 
994 |a 2016 
998 |g 118055917  |a Strowitzki, Thomas  |m 118055917:Strowitzki, Thomas  |d 910000  |d 910400  |e 910000PS118055917  |e 910400PS118055917  |k 0/910000/  |k 1/910000/910400/  |p 1  |x j 
999 |a KXP-PPN1656587319  |e 3388666407 
BIB |a Y 
JSO |a {"person":[{"display":"Strowitzki, Thomas","family":"Strowitzki","given":"Thomas","role":"aut"}],"language":["eng"],"origin":[{"dateIssuedKey":"2016","publisher":"BioMed Central","publisherPlace":"London","dateIssuedDisp":"2016"}],"note":["Wissenschaftlicher Aufsatz. - Aus: Reproductive Biology and Endocrinology, 14 (2016), Nr. 1. pp. 1-12. ISSN 1477-7827"],"type":{"media":"Online-Ressource","bibl":"book"},"title":[{"title":"Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)","title_sort":"Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)"}],"recId":"1656587319","name":{"displayForm":["Thomas Strowitzki, Waldemar Kuczynski, Arnd Müller and Peter Bias"]},"physDesc":[{"extent":"1 Online-Ressource (12 Seiten)"}],"id":{"doi":["10.1186/s12958-015-0135-8"],"uri":["urn:nbn:de:bsz:16-heidok-200753"],"eki":["1656587319"]}} 
SRT |a STROWITZKIRANDOMIZED2016